Global Blood Therapeutics, Inc.
MODULATORS OF HEMOGLOBIN

Last updated:

Abstract:

The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.

Status:
Application
Type:

Utility

Filling date:

4 May 2020

Issue date:

18 Feb 2021